TABLE 7

Comparison of the degrees of interactions between several paired drugs in various species using different dosing regimens

SubstrateInhibitor or InducerChange of AUCDosing RegimenSpeciesReference
MDZKTZ16-fold increase3 doses of 200 mg KTZ every 12 h, p.o.; 90 min after last dose of KTZ, 6 mg MDZ plus 200 mg KTZ, p.o.HumansTsunoda et al., 1999
7.7-fold increase200 mg KTZ for 12 days, p.o.; 1 h after the last dose of KTZ, 10 mg MDZ, p.o.HumansLam et al., 2003
5.0-fold increase200 mg KTZ, p.o.; 2 h later, 2 mg MDZ, p.o.HumansMcCrea et al., 1999
6.5-fold increase10 mg/kg KTZ, i.p.; 30 min later, 15 mg/kg MDZ, i.g.; 180 min later, 5 mg/kg KTZ, i.p., to maintain serum KTZ concentrations at ≥2 μg/mlSprague-Dawley ratsKotegawa et al., 2002
1.5-fold increase10 mg/kg KTZ, i.p.; 30 min later, 5 mg/kg MDZ, i.v.; 180 min later, 5 mg/kg KTZ, i.p., to maintain serum KTZ concentrations at ≥2 μg/mlSprague-Dawley ratsKotegawa et al., 2002
3.3-fold increase40 mg/kg KTZ, p.o.; 45 min later, 2.5 mg/kg MDZ, p.o.FVB/N miceGranvil et al., 2003
6.3-fold increase40 mg/kg KTZ, p.o.; 45 min later, 2.5 mg/kg MDZ, p.o.CYP3A4-humanized FVB/N miceGranvil et al., 2003
2.8-fold increase50 mg/kg KTZ, i.p.; 1 h later, 1 mg/kg MDZ in a cocktail, p.o.CD-1 miceThis study
PCN10% increase10 mg/kg PCN for 3 days, i.g.; 0.3 mg/kg MDZ, i.v.C57BL/6J micePang et al., 2011
25-fold decrease40 mg/kg PCN for 3 days, i.p.; 1 mg/kg MDZ in a cocktail, p.o.CD-1 miceThis study
PHEα-NF1.8-fold increase7 mg/kg α-NF, i.v.; 15 min later, 5 mg/kg PHE, i.v.Sprague-Dawley ratsZhuang et al., 2013
2.3-fold increase100 mg/kg α-NF, i.p.; 1 h later 2.8 mg/kg PHE in a cocktail, p.o.CD-1 miceThis study
3-MC4.9-fold decrease20 mg/kg 3-MC for 2 days, p.o.; 20 mg/kg PHE, i.v.Wistar ratsKlippert et al., 1983
13-fold decrease20 mg/kg 3-MC for 2 days, p.o.; 20 mg/kg PHE, i.d.Wistar ratsKlippert et al., 1983
33-fold decrease50 mg/kg 3-MC for 3 days, i.p.; 2.8 mg/kg PHE in a cocktail, p.o.CD-1 miceThis study